AGM 2026: All 4 resolutions passed with 100 percent approval

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.3%Reaction day

₹35.67

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+5.0% vs market

Pharmaceuticals peers, median of 176sector-0.2%+5.5% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 5.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.3+0.3+5.0-0.2+5.5

Next day

+2.1-0.2+2.3-0.5+2.5

+5.1+0.4+4.7-0.1+5.2

+6.4+0.2+6.2-0.0+6.4

+11.0+0.5+10.5+0.5+10.5

+8.1+0.8+7.3+0.5+7.6

+9.3-0.8+10.1+0.7+8.6

15d

+14.9-2.1+17.0+0.2+14.7

+0.9+0.2+0.7+2.1-1.2

+8.5-9.2+17.6-6.7+15.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 176Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Terce Laboratories held its 41st AGM on 21 Aug 2026 via video conferencing. All 4 resolutions passed. Key items: adoption of FY26 audited financials, re-appointment of Mr. Natwarbhai Prajapati as Director, re-appointment of Mr. Aalap Prajapati as MD and CEO for 3 years from 28 Oct 2026, and ratification of cost auditor (KV M and Co) remuneration for FY27. Of 77.91 lakh outstanding shares, 34.71 lakh (44.55%) voted, with 100 percent in favor of every resolution.

Likely market impact

Routine AGM business. All resolutions passed unanimously with no dissent. No material impact expected on stock price.